11/01/2021 |
SynAct Pharma AB |
Thomas Jonassen |
Member of the Board of Directors, Other senior executive |
Yes |
Merger decrease |
SynAct Pharma AB |
Share |
SE0008241491 |
06/01/2021 |
2,296,651 |
Quantity |
0.00 |
SEK |
|
Notification
|
23/07/2020 |
SynAct Pharma AB |
Thomas Jonassen |
Board of Director, Chief Strategy Officer / Styrelseledamot, CSO |
Yes |
Exercise decrease |
SYNACT TO 2 |
Subcription warrant |
SE0013409620 |
22/07/2020 |
29,840 |
Quantity |
0.00 |
SEK |
|
Notification
|
23/07/2020 |
SynAct Pharma AB |
Thomas Jonassen |
Board of Director, Chief Strategy Officer / Styrelseledamot, CSO |
Yes |
Exercise increase |
SYNACT |
Share |
SE0008241491 |
22/07/2020 |
29,840 |
Quantity |
6.70 |
SEK |
|
Notification
|
22/07/2020 |
SynAct Pharma AB |
Torbjörn Bjerke |
Chairman of the Board / Styrelseordförande |
Yes |
Exercise decrease |
SYNACT TO 2 |
Subcription warrant |
SE0013409620 |
22/07/2020 |
29,840 |
Quantity |
0.00 |
SEK |
|
Notification
|
22/07/2020 |
SynAct Pharma AB |
Torbjörn Bjerke |
Chairman of the Board / Styrelseordförande |
Yes |
Exercise increase |
SYNACT |
Share |
SE0008241491 |
22/07/2020 |
29,840 |
Quantity |
6.70 |
SEK |
|
Notification
|
22/07/2020 |
SynAct Pharma AB |
Terje Kalland |
Board of Director / Styrelseledamot |
|
Exercise decrease |
SYNACT TO 2 |
Subcription warrant |
SE0013409620 |
22/07/2020 |
29,840 |
Quantity |
0.00 |
SEK |
|
Notification
|
22/07/2020 |
SynAct Pharma AB |
Terje Kalland |
Board of Director / Styrelseledamot |
|
Exercise increase |
SYNACT |
Share |
SE0008241491 |
22/07/2020 |
29,840 |
Quantity |
6.70 |
SEK |
|
Notification
|
15/07/2020 |
SynAct Pharma AB |
John Haurum |
Board of Director / Styrelseledamot |
Yes |
Exercise decrease |
SYNACT TO 2 |
Subcription warrant |
SE0013409620 |
09/07/2020 |
29,840 |
Quantity |
0.00 |
SEK |
|
Notification
|
15/07/2020 |
SynAct Pharma AB |
John Haurum |
Board of Director / Styrelseledamot |
Yes |
Exercise increase |
SYNACT |
Share |
SE0008241491 |
09/07/2020 |
29,840 |
Quantity |
6.70 |
SEK |
|
Notification
|
14/07/2020 |
SynAct Pharma AB |
Jeppe Øvlesen |
CEO / Verkställande direktör |
Yes |
Exercise decrease |
SYNACT TO 2 |
Subcription warrant |
SE0013409620 |
10/07/2020 |
29,840 |
Quantity |
0.00 |
SEK |
|
Notification
|